438 related articles for article (PubMed ID: 32030554)
1. The use of autologous platelet-rich plasma (PRP) versus no intervention in women with low ovarian reserve undergoing fertility treatment: a non-randomized interventional study.
Melo P; Navarro C; Jones C; Coward K; Coleman L
J Assist Reprod Genet; 2020 Apr; 37(4):855-863. PubMed ID: 32030554
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of intra-ovarian injection of autologous platelet-rich plasma in women with poor responders: a systematic review and meta-analysis.
Vahabi Dastjerdi M; Sheibani S; Taheri M; Hezarcheshmeh FK; Jahangirian J; Jazayeri M; Hosseinirad H; Doohandeh T; Valizadeh R
Arch Gynecol Obstet; 2024 Jun; 309(6):2323-2338. PubMed ID: 38589612
[TBL] [Abstract][Full Text] [Related]
3. Platelet-rich plasma (PRP) treatment of the ovaries significantly improves fertility parameters and reproductive outcomes in diminished ovarian reserve patients: a systematic review and meta-analysis.
Éliás M; Kónya M; Kekk Z; Turan C; das Virgens IPA; Tóth R; Keszthelyi M; Hegyi P; Várbíró S; Sipos M
J Ovarian Res; 2024 May; 17(1):104. PubMed ID: 38760869
[TBL] [Abstract][Full Text] [Related]
4. Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency.
Cakiroglu Y; Saltik A; Yuceturk A; Karaosmanoglu O; Kopuk SY; Scott RT; Tiras B; Seli E
Aging (Albany NY); 2020 Jun; 12(11):10211-10222. PubMed ID: 32507764
[TBL] [Abstract][Full Text] [Related]
5. A narrative review of platelet-rich plasma (PRP) in reproductive medicine.
Sharara FI; Lelea LL; Rahman S; Klebanoff JS; Moawad GN
J Assist Reprod Genet; 2021 May; 38(5):1003-1012. PubMed ID: 33723748
[TBL] [Abstract][Full Text] [Related]
6. Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance.
Morin SJ; Patounakis G; Juneau CR; Neal SA; Scott RT; Seli E
Hum Reprod; 2018 Aug; 33(8):1489-1498. PubMed ID: 30010882
[TBL] [Abstract][Full Text] [Related]
7. Intra-ovarian infusion of autologous platelet-rich plasma in women with poor ovarian reserve: A before and after study.
Hosseinisadat R; Farsi Nejad A; Mohammadi F
Eur J Obstet Gynecol Reprod Biol; 2023 Jan; 280():60-63. PubMed ID: 36403398
[TBL] [Abstract][Full Text] [Related]
8. First data on in vitro fertilization and blastocyst formation after intraovarian injection of calcium gluconate-activated autologous platelet rich plasma.
Sills ES; Rickers NS; Li X; Palermo GD
Gynecol Endocrinol; 2018 Sep; 34(9):756-760. PubMed ID: 29486615
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: A retrospective study according to the POSEIDON criteria.
Farimani M; Nazari A; Mohammadi S; Anvari Aliabad R
Reprod Biol Endocrinol; 2021 Sep; 19(1):137. PubMed ID: 34496887
[TBL] [Abstract][Full Text] [Related]
10. Ovarian reserve parameters and IVF outcomes in 510 women with poor ovarian response (POR) treated with intraovarian injection of autologous platelet rich plasma (PRP).
Cakiroglu Y; Yuceturk A; Karaosmanoglu O; Kopuk SY; Korun ZEU; Herlihy N; Scott RT; Tiras B; Seli E
Aging (Albany NY); 2022 Mar; 14(6):2513-2523. PubMed ID: 35320118
[TBL] [Abstract][Full Text] [Related]
11. Ovarian reserve and PGD treatment outcome in women with myotonic dystrophy.
Srebnik N; Margalioth EJ; Rabinowitz R; Varshaver I; Altarescu G; Renbaum P; Levi-Lahad E; Weintraub A; Eldar-Geva T
Reprod Biomed Online; 2014 Jul; 29(1):94-101. PubMed ID: 24813161
[TBL] [Abstract][Full Text] [Related]
12. A double-blind randomised controlled trial on the effect of dehydroepiandrosterone on ovarian reserve markers, ovarian response and number of oocytes in anticipated normal ovarian responders.
Yeung T; Chai J; Li R; Lee V; Ho PC; Ng E
BJOG; 2016 Jun; 123(7):1097-105. PubMed ID: 26663817
[TBL] [Abstract][Full Text] [Related]
13. AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF/ICSI cycles.
Dai X; Wang Y; Yang H; Gao T; Yu C; Cao F; Xia X; Wu J; Zhou X; Chen L
Sci Rep; 2020 Nov; 10(1):19750. PubMed ID: 33184364
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate does not affect ovarian reserve or subsequent assisted reproductive technology outcomes.
Boots CE; Hill MJ; Feinberg EC; Lathi RB; Fowler SA; Jungheim ES
J Assist Reprod Genet; 2016 May; 33(5):647-656. PubMed ID: 26943917
[TBL] [Abstract][Full Text] [Related]
15. Ovarian Rejuvenation Through Platelet-Rich Autologous Plasma (PRP)-a Chance to Have a Baby Without Donor Eggs, Improving the Life Quality of Women Suffering from Early Menopause Without Synthetic Hormonal Treatment.
Petryk N; Petryk M
Reprod Sci; 2020 Nov; 27(11):1975-1982. PubMed ID: 32700285
[TBL] [Abstract][Full Text] [Related]
16. Effects of Intraovarian Injection of Autologous Platelet-Rich Plasma on Ovarian Rejuvenation in Poor Responders and Women with Primary Ovarian Insufficiency.
Aflatoonian A; Lotfi M; Saeed L; Tabibnejad N
Reprod Sci; 2021 Jul; 28(7):2050-2059. PubMed ID: 33683669
[TBL] [Abstract][Full Text] [Related]
17. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
[TBL] [Abstract][Full Text] [Related]
18. The effect of ovarian injection of autologous platelet rich plasma in patients with poor ovarian responder: a systematic review and meta-analysis.
Li X; Liu H; Lin G; Xu L
Front Endocrinol (Lausanne); 2023; 14():1292168. PubMed ID: 38155954
[TBL] [Abstract][Full Text] [Related]
19. Biopsying, fragmentation and autotransplantation of fresh ovarian cortical tissue in infertile women with diminished ovarian reserve.
Lunding SA; Pors SE; Kristensen SG; Landersoe SK; Jeppesen JV; Flachs EM; Pinborg A; Macklon KT; Pedersen AT; Andersen CY; Andersen AN
Hum Reprod; 2019 Oct; 34(10):1924-1936. PubMed ID: 31593582
[TBL] [Abstract][Full Text] [Related]
20. An audit of clinical outcomes following ovarian administration of platelet-rich plasma (PRP) in women with severe diminished ovarian reserve.
Tremellen K; Pacella-Ince L
Aust N Z J Obstet Gynaecol; 2022 Oct; 62(5):767-772. PubMed ID: 35726795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
